Clinical Trial Update: BAT1308 in Combination With Platinum-containing Chemotherapy is Used for the First-line Treatment of Advanced or Recurrent dMMR Endometrial Cancer [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update indicates BAT1308 in combination with platinum-containing chemotherapy for first-line treatment of advanced or recurrent dMMR endometria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• BAT1308 (BAT1308)

Snippet

Sponsor: Bio-Thera Solutions | Conditions: Endometrial Cancer | Phase 2, Phase 3 | Status: TERMINATED